HS Code 30043190.0 โ Medicaments containing insulin (retail)
Chapter 30 (Pharmaceutical Products) ยท Heading 3004 (Medicaments put up in measured doses or for retail sale) ยท Last updated: April 2026 ยท Source: Indian Customs (DGFT) Records
HS Code 30043190.0 (Medicaments containing insulin (retail)) is one of India's most significant pharmaceutical export classifications under Chapter 30 of the Harmonized System. With a total trade value of $386.8K across 68 shipments, this code covers 4 distinct pharmaceutical products exported by 14 Indian manufacturers to 26 countries. The leading product under this classification is Gliclazide at $165.3K, followed by Pioglitazone and Glimepiride.
The top importing markets include Netherlands, Hungary, United States. The top 5 products account for 100.0% of total trade under this code. Average transaction value is $5.7K. Leading exporters include MYLAN LABORATORIES LIMITED and INDOCO REMEDIES LIMITED. Data sourced from Indian Customs (DGFT) shipping bill records.

Products Exported Under HS Code 30043190.0
4 pharmaceutical products classified under this code, ranked by trade value
| Rank | Product | Trade Value | Transactions | Avg Price | Suppliers |
|---|---|---|---|---|---|
| #1 | Gliclazide | $165.3K | 16 | $0.34 | 3 |
| #2 | Pioglitazone | $117.5K | 25 | $0.04 | 2 |
| #3 | Glimepiride | $102.9K | 23 | $0.02 | 3 |